These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16782485)

  • 21. Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential.
    Rucker JJ
    BMJ; 2015 May; 350():h2902. PubMed ID: 26014506
    [No Abstract]   [Full Text] [Related]  

  • 22. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)].
    Votava Z; Podvalová I; Vojtĕchovský M
    Arzneimittelforschung; 1966 Feb; 16(2):220-2. PubMed ID: 6014083
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hallucinogenic drugs and the psychopharmacology of the conditioned reflex].
    Sivadjian J
    Therapie; 1970; 25(6):1059-66. PubMed ID: 5509533
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychedelic drugs and mystical experience.
    Pahnke WN
    Int Psychiatry Clin; 1969; 5(4):149-62. PubMed ID: 4892137
    [No Abstract]   [Full Text] [Related]  

  • 26. Dynamics of psychedelic drug abuse. A clinical study.
    Bowers M; Chipman A; Schwartz A; Dann OT
    Arch Gen Psychiatry; 1967 May; 16(5):560-6. PubMed ID: 5337259
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hallucinogenic spatial disorientation.
    Cohen LA
    Int J Neuropsychiatry; 1965 Aug; 1(4):347-51. PubMed ID: 4955762
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of hallucinogens on electroencephalograms].
    Oughourlian JM; Rougeul A; Verdeaux J
    Therapie; 1971; 26(5):953-68. PubMed ID: 5160349
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
    Dyer DC
    J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
    [No Abstract]   [Full Text] [Related]  

  • 31. Lysergamides revisited.
    Pfaff RC; Huang X; Marona-Lewicka D; Oberlender R; Nichols DE
    NIDA Res Monogr; 1994; 146():52-73. PubMed ID: 8742794
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
    Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 34. Some aspects of the current drug scene with emphasis on drugs in use by adolescents.
    Louria DB
    Pediatrics; 1968 Dec; 42(6):904-11. PubMed ID: 5726384
    [No Abstract]   [Full Text] [Related]  

  • 35. Discriminable stimuli produced by hallucinogens.
    Kuhn DM; White FJ; Appel JB
    Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychedelic drugs.
    Kieffer SN; Mortiz TB
    Pa Med; 1968 Apr; 71(4):57-67. PubMed ID: 4870533
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychedelic drugs.
    Kieffer SN; Moritz TB
    Pa Med; 1968 Apr; 71(4):57-67. PubMed ID: 4869313
    [No Abstract]   [Full Text] [Related]  

  • 38. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental psychoses induced by sleep deprivation and hallucinogens in abstaining alcoholics].
    Vojtĕchovský M; Skála J; Hort V
    Cesk Psychiatr; 1969 Jun; 65(3):137-49. PubMed ID: 5790305
    [No Abstract]   [Full Text] [Related]  

  • 40. [LSD-25 and UML decrease the levels of 5-hydroxyindoleacetic acid in the brain of rat].
    Torre M; Bogetto F; Torre E
    Boll Soc Ital Biol Sper; 1976 Nov; 52(21):1835-7. PubMed ID: 1026256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.